TrialInternational clinical psychopharmacology2014

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.

Mohammed Y Alam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.